Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.21.2
Segment Information (Tables)
9 Months Ended
Sep. 30, 2021
Segment Reporting [Abstract]  
Schedule of segment information
    Cannabis and Medical Marijuana Segment     Facility Operations Related     Corporate and Eliminations     Consolidated  
Three months ended September 30, 2021                                
Net revenue   $ 9,972     $ 1,482,649     $ -     $ 1,492,624  
Operating income (loss)     6,426       196,565       (116,664 )     86,327  
Interest income     -       -       16,269       16,269  
Interest expense     -       9,381       7,333       16,714  
Property additions     -       92,013       1,264       93,277  
Depreciation and amortization     -       13,570       1,461       15,031  
                                 
Three months ended September 30, 2020                                
Net revenue   $ 11,730     $ 1,219,800     $ -     $ 1,231,530  
Operating income (loss)     4,516       (230,490 )     (189,005 )     (414,979 )
Interest income     8       -       24,960       24,968  
Interest expense     -       9,517       (1,004 )     8,513  
Property additions     -       6,490       2,581       9,071  
Depreciation and amortization     -       3,892       2,038       5,930  
                                 
Nine months ended September 30, 2021                                
Net revenue   $ 31,176     $ 4,154,711     $ -     $ 4,185,887  
Operating income (loss)     20,876       11,062       (417,644 )     (385,706 )
Interest income     -       -       49,003       49,003  
Interest expense     -       27,421       (23,032 )     4,389  
Property additions     -       107,290       1,264       108,554  
Depreciation and amortization     -       29,923       4,382       34,305  
Total assets     396,907       1,997,786       2,153,940       4,548,633  
                                 
Nine months ended September 30, 2020                                
Net revenue   $ 36,297     $ 3,503,563     $ -     $ 3,539,860  
Operating income (loss)     (16,624 )     (174,878 )     (665,076 )     (856,578 )
Interest income     -       -       65,504       65,504  
Interest expense     -       25,829       (3,132 )     22,697  
Property additions     -       23,231       7,593       30,824  
Depreciation and amortization     -       10,190       4,679       14,869  
Total assets     2,095,569       1,955,675       702,561       4,753,805  
Schedule of reconciliation of revenue from segments to consolidated

The following table reconciles operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes, as presented in the unaudited condensed consolidated income statements:

 

Schedule of reconciliation of revenue from segments to consolidated

    2021     2020     2021     2020  
    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2021     2020     2021     2020  
Operating loss   $ 86,327     $ (414,979 )   $ (385,706 )   $ (856,578 )
Gain (loss) on investments     (2,427 )     (2,758 )     (9,001 )     (8,676 )
Interest income     16,269       24,968       49,003       65,504  
Interest expense     (16,714 )     (8,513 )     (43,899 )     (22,697 )
Gain on equipment disposals     (671 )     3,372       761       3,372  
EIDL Advance     -       -       -       10,000  
Other income     4,032       7,994       15,429       24,352  
                                 
Income before income taxes   $ 86,816     $ (389,916 )   $ (373,413 )   $ (784,723 )